These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18088602)

  • 81. Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect.
    Mescka CP; Wayhs CA; Vanzin CS; Biancini GB; Guerreiro G; Manfredini V; Souza C; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2013 Feb; 31(1):21-4. PubMed ID: 23137711
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of complete water fasting and regeneration diet on kidney function, oxidative stress and antioxidants.
    Mojto V; Gvozdjakova A; Kucharska J; Rausova Z; Vancova O; Valuch J
    Bratisl Lek Listy; 2018; 119(2):107-111. PubMed ID: 29455546
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Maple syrup urine disease in Brazilian patients: variants and clinical phenotype heterogeneity.
    Margutti AVB; Silva WA; Garcia DF; de Molfetta GA; Marques AA; Amorim T; Prazeres VMG; Boy da Silva RT; Miura IK; Seda Neto J; Santos ES; Santos MLSF; Lourenço CM; Tonon T; Sperb-Ludwig F; de Souza CFM; Schwartz IVD; Camelo JS
    Orphanet J Rare Dis; 2020 Nov; 15(1):309. PubMed ID: 33131499
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
    Xu J; Jakher Y; Ahrens-Nicklas RC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Investigation of L - Carnitine Concentrations in Treated Patients with Maple Syrup Urine Disease.
    Kumru B; Oztürk Hismi B
    J Pediatr Genet; 2019 Sep; 8(3):133-136. PubMed ID: 31406618
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Neuroprotective Effect of Creatine and Pyruvate on Enzyme Activities of Phosphoryl Transfer Network and Oxidative Stress Alterations Caused by Leucine Administration in Wistar Rats.
    Rieger E; de Franceschi ID; Preissler T; Wannmacher CMD
    Neurotox Res; 2017 Nov; 32(4):575-584. PubMed ID: 28612295
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.
    Taschetto L; Scaini G; Zapelini HG; Ramos ÂC; Strapazzon G; Andrade VM; Réus GZ; Michels M; Dal-Pizzol F; Quevedo J; Schuck PF; Ferreira GC; Streck EL
    Metab Brain Dis; 2017 Oct; 32(5):1507-1518. PubMed ID: 28550500
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
    Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
    Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure.
    Sun H; Olson KC; Gao C; Prosdocimo DA; Zhou M; Wang Z; Jeyaraj D; Youn JY; Ren S; Liu Y; Rau CD; Shah S; Ilkayeva O; Gui WJ; William NS; Wynn RM; Newgard CB; Cai H; Xiao X; Chuang DT; Schulze PC; Lynch C; Jain MK; Wang Y
    Circulation; 2016 May; 133(21):2038-49. PubMed ID: 27059949
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.
    Vogel KR; Arning E; Wasek BL; McPherson S; Bottiglieri T; Gibson KM
    Orphanet J Rare Dis; 2014 May; 9():73. PubMed ID: 24886632
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Neurological damage in MSUD: the role of oxidative stress.
    Sitta A; Ribas GS; Mescka CP; Barschak AG; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2014 Mar; 34(2):157-65. PubMed ID: 24220995
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD).
    Skvorak KJ; Hager EJ; Arning E; Bottiglieri T; Paul HS; Strom SC; Homanics GE; Sun Q; Jansen EE; Jakobs C; Zinnanti WJ; Gibson KM
    Biochim Biophys Acta; 2009 Oct; 1792(10):1004-10. PubMed ID: 19699299
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells.
    Lu G; Sun H; She P; Youn JY; Warburton S; Ping P; Vondriska TM; Cai H; Lynch CJ; Wang Y
    J Clin Invest; 2009 Jun; 119(6):1678-87. PubMed ID: 19411760
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Amino acids levels and lipid peroxidation in maple syrup urine disease patients.
    Barschak AG; Sitta A; Deon M; Busanello EN; Coelho DM; Cipriani F; Dutra-Filho CS; Giugliani R; Wajner M; Vargas CR
    Clin Biochem; 2009 Apr; 42(6):462-6. PubMed ID: 19121297
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
    Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.
    Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Oxidative stress markers in bipolar disorder: a meta-analysis.
    Andreazza AC; Kauer-Sant'anna M; Frey BN; Bond DJ; Kapczinski F; Young LT; Yatham LN
    J Affect Disord; 2008 Dec; 111(2-3):135-44. PubMed ID: 18539338
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Maple syrup urine disease].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 2001; (34 Pt 2):137-9. PubMed ID: 11528661
    [No Abstract]   [Full Text] [Related]  

  • 99. Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles.
    Barschak AG; Marchesan C; Sitta A; Deon M; Giugliani R; Wajner M; Vargas CR
    Clin Biochem; 2008 Mar; 41(4-5):317-24. PubMed ID: 18088602
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.